Ng Yi Shiau, Thompson Kyle, Loher Daniela, Hopton Sila, Falkous Gavin, Hardy Steven A, Schaefer Andrew M, Shaunak Sandip, Roberts Mark E, Lilleker James B, Taylor Robert W
Wellcome Centre for Mitochondrial Research, Faculty of Medical Sciences, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
Directorate of Neurosciences, Royal Victoria Infirmary, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Front Genet. 2020 Feb 25;11:24. doi: 10.3389/fgene.2020.00024. eCollection 2020.
Mitochondrial complex I deficiency is associated with a diverse range of clinical phenotypes and can arise due to either mitochondrial DNA (mtDNA) or nuclear gene defects. We investigated two adult patients who exhibited non-syndromic neurological features and evidence of isolated mitochondrial complex I deficiency in skeletal muscle biopsies. The first presented with indolent myopathy, progressive since age 17, while the second developed deafness around age 20 and other relapsing-remitting neurological symptoms since. A novel, likely frameshift variant in (m.14512_14513del) and a novel maternally-inherited transversion mutation in were identified, respectively. Skewed tissue segregation of mutant heteroplasmy level was observed; the mutant heteroplasmy levels of both variants were greater than 70% in muscle homogenate, however, in blood the variant was undetectable while the mutant heteroplasmy level of the variant was low (12%). Assessment of complex I assembly by Blue-Native PAGE demonstrated a decrease in fully assembled complex I in the muscle of both cases. SDS-PAGE and immunoblotting showed decreased levels of mtDNA-encoded ND1 and several nuclear encoded complex I subunits in both cases, consistent with functional pathogenic consequences of the identified variants. Pathogenicity of the m.14512_14513del was further corroborated by single-fiber segregation studies.
线粒体复合体I缺乏症与多种临床表型相关,可由线粒体DNA(mtDNA)或核基因缺陷引起。我们研究了两名成年患者,他们表现出非综合征性神经学特征,且骨骼肌活检中有孤立的线粒体复合体I缺乏症证据。第一名患者自17岁起出现进展缓慢的肌病,第二名患者在20岁左右出现耳聋,此后出现其他复发-缓解性神经症状。分别鉴定出一个新的、可能的移码变异(m.14512_14513del)和一个新的母系遗传颠换突变。观察到突变异质性水平的组织偏态分离;两种变异在肌肉匀浆中的突变异质性水平均大于70%,然而,在血液中,m.14512_14513del变异无法检测到,而另一种变异的突变异质性水平较低(12%)。通过蓝色非变性聚丙烯酰胺凝胶电泳(Blue-Native PAGE)评估复合体I组装情况,结果显示两例患者肌肉中完全组装的复合体I均减少。十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)和免疫印迹显示,两例患者中mtDNA编码的ND1和几个核编码的复合体I亚基水平均降低,这与所鉴定变异的功能致病性后果一致。单纤维分离研究进一步证实了m.14512_14513del的致病性。